Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms.
Pulsed corticosteroid treatment in MS patients stabilizes disease activity following natalizumab withdrawal prior to switching to fingolimod.
Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPARβ/δ: a potential therapeutic role for CNS autoimmune disease.
Long-term safety of fingolimod: Interim evaluation of data from the longterms trial.
Reversible pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis.
Development of Quinoline-2,4(1H,3H)-diones as Potent and Selective ligands of the Cannabinoid Type 2 Receptor.
Vaccine-associated inflammatory diseases of the central nervous system: from signals to causation.
Activation of oligodendroglial Stat3 is required for efficient remyelination.
Is it necessary to perform connective tissue disorders laboratory tests when a patient experiences the first demyelinating attack?
Diagnostic work-up and therapeutic options in management of pediatric status epilepticus.
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis.
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis.
Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled - MS arising during Tocilizumab therapy for rheumatoid arthritis.
The clinical features and diagnosis of Metachromatic leukodystrophy: A case series of Iranian Pediatric Patients.
Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression.
Use of bodily sensations as a risk assessment tool: exploring people with Multiple Sclerosis' views on risks of negative interactions between herbal medicine and conventional drug therapies.
Do patient and proxy agree? Long-term changes in multiple sclerosis physical impact and walking ability on patient-reported outcome scales.
Proteomics Urine Analysis of Pregnant Women Suffering from Multiple Sclerosis.
Cluster headache as a first manifestation of multiple sclerosis: case report and literature review.
In Vivo Visualization of (Auto)Immune Processes in the Central Nervous System of Rodents.
Mutagenesis of the Aquaporin 4 Extracellular Domains Defines Restricted Binding Patterns of Pathogenic Neuromyelitis Optica IgG.
Measurement characteristics and clinical utility of the Brief Pain Inventory-Short Form for individuals with multiple sclerosis.
Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases.
Pages
« first
‹ previous
…
700
701
702
703
704
705
706
707
708
…
next ›
last »